The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of nine new drugs, including three anti-inflammation fixed dose combinations (FDCs) and six antidiabetic combinations ...
Figure 1. Bioequivalence study of Metformin XR 1000 Mg. Mean plasma concentration (ng/mL) Vs Time (h). Arithmetic scale. Figure 2. Bioequivalence study of Metformin XR 1000 Mg. Mean plasma ...
Lupin has received tentative approval from the Food and Drug Administration for sitagliptin and metformin hydrochloride tablets, 50 mg/500 mg and 50 mg/1000 mg, which is a generic of Merck Sharp & ...
The expert committee of the National Pharmaceutical Pricing Authority (NPPA) has recommended retail prices of 24 anti-diabetes drug combinations with components sitagliptin and dapagliflozin, which ...
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of Fixed-Dose Combination (FDC) of Vildagliptin and Metformin Hydrochloride in two different strengths under ...
The US Food and Drug Administration (USFDA) has granted final approval for the company's abbreviated new drug application (ANDA) for Metformin Hydrochloride extended-release tablets USP, 500 mg and ...
Mumbai, Baltimore: Drugmaker, Lupin Limited, has recently announced that the company has received tentative approval for its Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, 5 ...
Lupin has received tentative approval for its Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, 5 mg/1000 mg, 10 mg/1000 mg, 12.5 mg/1000 mg, and 25 rng/1000 mg, from the United ...
Drug firm Panacea Biotec on Tuesday said it has launched its VilACT brand tablets available in four formulations, for treatment of type 2 diabetes in India. The four formulations are Vildagliptin 50 ...
https://www.thehindubusinessline.com/companies/laurus-labs-gets-usfda-approval-for-metformin-tablets/article24816752.ece Copy Laurus Labs has received approval for ...
This leaflet answers some common questions about Metformin Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines ...
In Phase 3 studies, INVOKANA® plus metformin lowered blood sugar and reduced secondary endpoints of body weight and systolic blood pressure to a greater degree than metformin alone “INVOKAMET ™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results